🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Obtain interaction data between BI 201335 and Efavirenz to guide dosing for...
Status
Completed
Location
1220.20.41001 Boehringer Ingelheim Investigational Site
Start Date
2011-06
Trial ID
NCT01371006
Treatments Being Tested
The objective of the current study is to investigate the relative bioavaila...
Status
Completed
Location
1220.46.1 Boehringer Ingelheim Investigational Site
Start Date
2013-01
Trial ID
NCT01764945
The objective of this trial is to investigate tolerability, safety, pharmac...
Status
Completed
Location
1241.25.002 Boehringer Ingelheim Investigational Site
Start Date
2012-02
Trial ID
NCT01528735
Treatments Being Tested
The current Standard of Care (SOC) for chronic HCV infection, which is pegy...
Status
Completed
Location
1220.14.003 Boehringer Ingelheim Investigational Site
Start Date
2009-07
Trial ID
NCT00947349
The aim of this trial is to evaluate the safety and efficacy of BI 201335 g...
Status
Completed
Location
1220.54.08104 Boehringer Ingelheim Investigational Site
Start Date
2012-04
Trial ID
NCT01579474
Treatments Being Tested
The objectives of this study are: 1. To evaluate the efficacy and safety o...
Status
Withdrawn
Location
Multiple Locations
Start Date
2012-09
Trial ID
NCT01608737
Treatments Being Tested
The objective of this study was to establish the relative bioavailability o...
Status
Completed
Location
Multiple Locations
Start Date
2008-01
Trial ID
NCT02182284
The substances BI 201335 and BI 207127 are being developed for the treatmen...
Status
Completed
Location
1241.21.0003 Boehringer Ingelheim Investigational Site
Start Date
2010-05
Trial ID
NCT01132313
Treatments Being Tested
To demonstrate that BI 201335 does not prolong the QT interval more than pl...
Status
Completed
Location
Multiple Locations
Start Date
2008-06
Trial ID
NCT02182310
Treatments Being Tested
The objective of this trial is to evaluate the efficacy and safety of two d...
Status
Completed
Location
1220.30.4303 Boehringer Ingelheim Investigational Site
Start Date
2011-04
Trial ID
NCT01343888
Treatments Being Tested